Robert Kramer - 23 Feb 2022 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
President and CEO, Director
Signature
/s/ S. Scott Lieberman, Attorney-in-fact
Issuer symbol
EBS
Transactions as of
23 Feb 2022
Net transactions value
-$146,308
Form type
4
Filing time
25 Feb 2022, 16:18:00 UTC
Previous filing
24 Feb 2022
Next filing
02 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Tax liability $59,924 -1,419 -0.87% $42.23* 161,303 23 Feb 2022 Direct F1
transaction EBS Common Stock Tax liability $86,384 -2,034 -1.3% $42.47* 159,269 24 Feb 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes.